コンテンツへスキップ
Merck
  • Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.

Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.

The Journal of pharmacology and experimental therapeutics (2014-06-12)
Tomohisa Mori, Naoki Uzawa, Haruyo Kazawa, Hirohiko Watanabe, Ayano Mochizuki, Masahiro Shibasaki, Kazumi Yoshizawa, Kimio Higashiyama, Tsutomu Suzuki
要旨

Previous studies have demonstrated that methylphenidate, MDMA (3,4-methylenedioxymethamphetamine), and other psychostimulants exert stimulant-like subjective effects in humans. Furthermore, MDMA and methylphenidate substitute for the discriminative stimulus effects of psychostimulants, such as amphetamine and cocaine, in animals, which suggests that MDMA and methylphenidate may produce similar discriminative stimulus effects in rats. However, there is no evidence regarding the similarities between the discriminative stimulus effects of MDMA and methylphenidate. To explore this issue, cross-substitution, substitution, and combination tests were conducted in rats that had been trained to discriminate between MDMA (2.5 mg/kg) or methylphenidate (5.0 mg/kg) and saline. In the cross-substitution tests, MDMA and methylphenidate did not cross-substitute for each other. In the substitution test, methamphetamine substituted for the discriminative stimulus effects of methylphenidate, but not for those of MDMA. Furthermore, ephedrine and bupropion, which activate dopaminergic and noradrenergic systems, substituted for the discriminative stimulus effects of methylphenidate. On the other hand, serotonin (5-HT) receptor agonists 5-HT1A and 5-HT2 fully substituted for the discriminative stimulus effects of MDMA. These results suggest that activation of the noradrenergic and dopaminergic systems is important for the discriminative stimulus effects of methylphenidate, whereas activation of the serotonergic system is crucial for the discriminative stimulus effects of MDMA. Even though MDMA, like psychostimulants, exerts stimulant-like effects, our findings clearly indicate that the discriminative stimulus effects of MDMA are distinctly different from those of other psychostimulants in rats.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
フルオキセチン 塩酸塩, solid
Sigma-Aldrich
プラゾシン 塩酸塩, ≥99.0% (HPLC)
Sigma-Aldrich
デシプラミン 塩酸塩, ≥98% (TLC), powder
Sigma-Aldrich
ハロペリドール, powder
Sigma-Aldrich
R-(−)-アポモルフィン 塩酸塩 ヘミ水和物, calcined, ≥98.5% (with NaOH, titration)
Sigma-Aldrich
メチルフェニデート 塩酸塩
Sigma-Aldrich
ブプロピオン 塩酸塩, ≥98% (HPLC), solid
Supelco
フルオキセチン 塩酸塩, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
メチルフェニデート 塩酸塩 溶液, (Racemic mixture), ampule of 1 mL, 1.0 mg/mL in methanol (as free base), certified reference material, Cerilliant®
USP
マレイン酸フルボキサミン, United States Pharmacopeia (USP) Reference Standard
Supelco
Desipramine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
USP
フルオキセチン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
マレイン酸フルボキサミン, solid
USP
ハロペリドール, United States Pharmacopeia (USP) Reference Standard
USP
ブプロピオン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
USP
デシプラミン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
USP
プラゾシン 塩酸塩, United States Pharmacopeia (USP) Reference Standard
R-(−)-アポモルフィン 塩酸塩 ヘミ水和物, European Pharmacopoeia (EP) Reference Standard
Supelco
フルオキセチン 塩酸塩, VETRANAL®, analytical standard
ハロペリドール, European Pharmacopoeia (EP) Reference Standard
デシプラミン 塩酸塩, European Pharmacopoeia (EP) Reference Standard
プラゾシン 塩酸塩, European Pharmacopoeia (EP) Reference Standard
ハロペリドール, European Pharmacopoeia (EP) Reference Standard
システム適合性用ハロペリドール, European Pharmacopoeia (EP) Reference Standard
マレイン酸フルボキサミン, European Pharmacopoeia (EP) Reference Standard
システム適合性用フルボキサミン, European Pharmacopoeia (EP) Reference Standard